Primary antibodies included anti--Catenin, anti-GSK3, anti-phospho-GSK3, anti-GAPDH, and anti--tubulin (Boster Biological Technology, Pleasanton, CA, United States), anti-Bcl2, anti-Bax, and anti-Cyclin D1 (Abcam plc, Cambridge, United Kingdom), anti-Akt and anti-phospho-Akt (Cell Signaling Technology, Danvers, MA, United Ststes), anti-Wnt10b, anti-CDK2, anti-CDK4, and anti-P21 (ABclonal, Wuhan, China), and anti-ki67 (Proteintech, Wuhan, China)
If you are taking a supplement and suspect it is causing harm, stop taking it and seek medical advice promptly
3 Treatment Implementation Begin your peptide injections with full training and support
New perspectives of nuclear receptor studies

Author contributions Mahmoud Hussein Hadwan (Conceptualization [equal], Data curation [equal], Formal analysis [equal], Funding acquisition [equal], Investigation [equal], Methodology [equal], Project administration [equal], Resources [equal], Software [equal], Supervision [equal], Validation [equal], Visualization [equal], Writingoriginal draft [equal], and Writingreview & editing [equal]), Abbas Ali Mohammed (Data curation [equal], Investigation [equal], Methodology [equal], Software [equal], and Writingreview & editing [equal]), Saeed Najavand (Data curation [equal], Project administration [equal], Resources [equal], Software [equal], Supervision [equal], Investigation [equal], Methodology [equal], and Writingreview & editing [equal]), Roaa Altaee (Investigation [equal], Methodology [equal], Validation [equal], and Writingreview & editing [equal]), and Asad Hadwan (Data curation [equal], Formal analysis [equal], Investigation [equal], Methodology [equal], Validation [equal], and Writingreview & editing [equal]) Conflicts of interest None declared
